MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gray, J. A.
Right arrow Articles by Roth, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gray, J. A.
Right arrow Articles by Roth, B. L.

Vol. 63, Issue 5, 961-972, May 2003

The Interaction of a Constitutively Active Arrestin with the Arrestin-Insensitive 5-HT2A Receptor Induces Agonist-Independent Internalization

John A. Gray, Anushree Bhatnagar, Vsevolod V. Gurevich, and Bryan L. Roth

Departments of Biochemistry (J.A.G., A.B., B.L.R.), Psychiatry (B.L.R.), and Neurosciences (B.L.R.), Case Western Reserve University School of Medicine, Cleveland, Ohio; and Department of Pharmacology, Vanderbilt University, Nashville, Tennessee (V.V.G.)

5-HT2A serotonin receptors are unusual among G-protein coupled receptors in that they can be internalized and desensitized, in some cell types, in an arrestin-independent manner. The molecular basis of the arrestin-insensitivity of 5-HT2A receptors is unknown but is probably caused, in part, by the apparent lack of agonist-induced 5-HT2A receptor phosphorylation. Because the arrestin-insensitivity of 5-HT2A receptors is cell-type selective, we used a "constitutively active" arrestin mutant that can interact with agonist-activated but nonphosphorylated receptors. We show here that this "constitutively active" arrestin mutant (Arr2-R169E) can force 5-HT2A receptors to be regulated by arrestins. Cotransfection of 5-HT2A receptors with Arr2-R169E induced agonist-independent 5-HT2A receptor internalization, and a constitutive translocation of the Arr2-R169E mutant to the plasma membrane, whereas wild-type Arrestin-2 had no effect. Additionally, Arr2-R169E, unlike wild-type arrestin-2, induced a significant decrease in efficacy of agonist-induced phosphoinositide hydrolysis with an unexpected increase in agonist potency. Radioligand binding assays demonstrated that the fraction of receptors in the high-affinity agonist binding-state increased with expression of Arr2-R169E, indicating that Arr2-R169E stabilizes the agonist-high affinity state of the 5-HT2A receptor (R*). Intriguingly, the agonist-independent interaction of Arr2-R169E with 5-HT2A receptors was inhibited by inverse agonist treatment and is thus probably caused by the high level of 5-HT2A receptor constitutive activity. This is the first demonstration that a constitutively active arrestin mutant can both induce agonist-independent internalization and stabilize the agonist-high affinity state of an arrestin-insensitive G protein coupled receptor.

Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
C. L. Schmid, K. M. Raehal, and L. M. Bohn
From the Cover: Agonist-directed signaling of the serotonin 2A receptor depends on {beta}-arrestin-2 interactions in vivo
PNAS, January 22, 2008; 105(3): 1079 - 1084.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. Janoshazi, M. Deraet, J. Callebert, V. Setola, S. Guenther, B. Saubamea, P. Manivet, J.-M. Launay, and L. Maroteaux
Modified Receptor Internalization upon Coexpression of 5-HT1B Receptor and 5-HT2B Receptors
Mol. Pharmacol., June 1, 2007; 71(6): 1463 - 1474.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
Z. Bhagwagar, R. Hinz, M. Taylor, S. Fancy, P. Cowen, and P. Grasby
Increased 5-HT2A Receptor Binding in Euthymic, Medication-Free Patients Recovered From Depression: A Positron Emission Study With [11C]MDL 100,907
Am J Psychiatry, September 1, 2006; 163(9): 1580 - 1587.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Barthet, F. Gaven, B. Framery, K. Shinjo, T. Nakamura, S. Claeysen, J. Bockaert, and A. Dumuis
Uncoupling and Endocytosis of 5-Hydroxytryptamine 4 Receptors: DISTINCT MOLECULAR EVENTS WITH DIFFERENT GRK2 REQUIREMENTS
J. Biol. Chem., July 29, 2005; 280(30): 27924 - 27934.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. J. van Koppen and K. H. Jakobs
Arrestin-Independent Internalization of G Protein-Coupled Receptors
Mol. Pharmacol., September 1, 2004; 66(3): 365 - 367.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Bhatnagar, D. J. Sheffler, W. K. Kroeze, B. Compton-Toth, and B. L. Roth
Caveolin-1 Interacts with 5-HT2A Serotonin Receptors and Profoundly Modulates the Signaling of Selected G{alpha}q-coupled Protein Receptors
J. Biol. Chem., August 13, 2004; 279(33): 34614 - 34623.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C.-H. Chen, M. M. Paing, and J. Trejo
Termination of Protease-activated Receptor-1 Signaling by {beta}-Arrestins Is Independent of Receptor Phosphorylation
J. Biol. Chem., March 12, 2004; 279(11): 10020 - 10031.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
W. K. Kroeze, D. J. Sheffler, and B. L. Roth
G-protein-coupled receptors at a glance
J. Cell Sci., December 15, 2003; 116(24): 4867 - 4869.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Xia, J. A. Gray, B. A. Compton-Toth, and B. L. Roth
A Direct Interaction of PSD-95 with 5-HT2A Serotonin Receptors Regulates Receptor Trafficking and Signal Transduction
J. Biol. Chem., June 6, 2003; 278(24): 21901 - 21908.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics